Resolution of inflammation by Resolvin D1 is essential for peroxisome proliferator-activated receptor-γ-mediated analgesia during postincisional pain development in type 2 diabetes

Anesthesiology

Volumn 123, Issue 6, 2015, Pages 1420-1434

  Saito, Takayuki ^a,b   Hasegawa Moriyama, Maiko ^a   Kurimoto, Tae ^a   Yamada, Tomotsugu ^a   Inada, Eichi ^b   Kanmura, Yuichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ARACHIDONATE 5 LIPOXYGENASE; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESOLVIN D1; ROSIGLITAZONE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; DOCOSAHEXAENOIC ACID;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POLARITY; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; EXPERIMENTAL INFLAMMATION; INCISION; MACROPHAGE; MALE; MECHANICAL HYPERALGESIA; MOUSE; NEUTROPHIL CHEMOTAXIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; TUNEL ASSAY; AGONISTS; ANALGESIA; ANIMAL; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; INFLAMMATION; PAIN, POSTOPERATIVE; PROCEDURES;

ANALGESIA; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; HYPOGLYCEMIC AGENTS; INFLAMMATION; MACROPHAGES; MALE; MICE; PAIN, POSTOPERATIVE; PPAR GAMMA; THIAZOLIDINEDIONES;

EID: 84947486475     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000892     Document Type: Article

References (49)

1. Falanga V, Wound healing and its impairment in the diabetic foot. Lancet 2005 366 1736 43
2. Ren K, Dubner R, Interactions between the immune and nervous systems in pain. Nat Med 2010 16 1267 76
3. Lawrence T, Natoli G, Transcriptional regulation of macrophage polarization: Enabling diversity with identity. Nat Rev Immunol 2011 11 750 61
4. Murray PJ, Wynn TA, Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011 11 723 37
5. Bensinger SJ, Tontonoz P, Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 2008 454 470 7
6. Bouhlel MA, Derudas B, Rigamonti E, Dièvart R, Brozek J, Haulon S, Zawadzki C, Jude B, Torpier G, Marx N, Staels B, Chinetti-Gbaguidi G, PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 2007 6 137 43
7. Hasegawa-Moriyama M, Kurimoto T, Nakama M, Godai K, Kojima M, Kuwaki T, Kanmura Y, Peroxisome proliferator-activated receptor-γ agonist rosiglitazone attenuates inflammatory pain through the induction of heme oxygenase-1 in macrophages. Pain 2013 154 1402 12
8. Hasegawa-Moriyama M, Ohnou T, Godai K, Kurimoto T, Nakama M, Kanmura Y, Peroxisome proliferator-activated receptor-γ agonist rosiglitazone attenuates postincisional pain by regulating macrophage polarization. Biochem Biophys Res Commun 2012 426 76 82
9. Serhan CN, Chiang N, Van Dyke TE, Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008 8 349 61
10. Tang Y, Zhang MJ, Hellmann J, Kosuri M, Bhatnagar A, Spite M, Proresolution therapy for the treatment of delayed healing of diabetic wounds. Diabetes 2013 62 618 27
11. Liao Z, Dong J, Wu W, Yang T, Wang T, Guo L, Chen L, Xu D, Wen F, Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway. Respir Res 2012 13 110
12. Zimmermann M, Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983 16 109 10
13. Pogatzki EM, Raja SN, A mouse model of incisional pain. A nesthesiology 2003 99 1023 7
14. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL, Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994 53 55 63
15. Cheng HT, Dauch JR, Hayes JM, Hong Y, Feldman EL, Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes. J Neuropathol Exp Neurol 2009 68 1229 43
16. Colucci M, Maione F, Bonito MC, Piscopo A, Di Giannuario A, Pieretti S, New insights of dimethyl sulphoxide effects (DMSO) on experimental in vivo models of nociception and inflammation. Pharmacol Res 2008 57 419 25
17. Xu ZZ, Zhang L, Liu T, Park JY, Berta T, Yang R, Serhan CN, Ji RR, Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med 2010 16 592 7, 1p following 597
18. Recchiuti A, Serhan CN, Pro-resolving lipid mediators (SPMs) and their actions in regulating miRNA in novel resolution circuits in inflammation. Front Immunol 2012 3 298
19. Sahbaie P, Li X, Shi X, Clark JD, Roles of Gr-1+ leukocytes in postincisional nociceptive sensitization and inflammation. A nesthesiology 2012 117 602 12
20. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL, Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002 196 1025 37
21. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LA, Perretti M, Rossi AG, Wallace JL, Resolution of inflammation: State of the art, definitions and terms. FASEB J 2007 21 325 32
22. Majai G, Sarang Z, Csomós K, Zahuczky G, Fésüs L, PPARγ-dependent regulation of human macrophages in phagocytosis of apoptotic cells. Eur J Immunol 2007 37 1343 54
23. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, Rose DW, Willson TM, Rosenfeld MG, Glass CK, A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ. Nature 2005 437 759 63
24. Ariel A, Serhan CN, New lives given by cell death: Macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation. Front Immunol 2012 3 4
25. Rocha AC, Fernandes ES, Quintão NL, Campos MM, Calixto JB, Relevance of tumour necrosis factor-α for the inflammatory and nociceptive responses evoked by carrageenan in the mouse paw. Br J Pharmacol 2006 148 688 95
26. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH, The pivotal role of tumour necrosis factor-α in the development of inflammatory hyperalgesia. Br J Pharmacol 1992 107 660 4
27. Sindrilaru A, Peters T, Wieschalka S, Baican C, Baican A, Peter H, Hainzl A, Schatz S, Qi Y, Schlecht A, Weiss JM, Wlaschek M, Sunderkötter C, Scharffetter-Kochanek K, An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest 2011 121 985 97
28. Preziosi P, Scapagnini U, Action of dimethylsulfoxide on acute inflammatory reactions. Curr Ther Res Clin Exp 1966 8 261 4
29. Ashley FL, Johnson AN, McConnell DV, Galloway DV, Machida RC, Sterling HE, Dimethyl sulfoxide and burn edema. Ann N Y Acad Sci 1967 141 463 4
30. Piercy V, Banner SE, Bhattacharyya A, Parsons AA, Sanger GJ, Smith SA, Bingham S, Thermal, but not mechanical, nociceptive behavior is altered in the Zucker Diabetic Fatty rat and is independent of glycemic status. J Diabetes Complications 1999 13 163 9
31. Fahey TJ III, Sadaty A, Jones WG II, Barber A, Smoller B, Shires GT, Diabetes impairs the late inflammatory response to wound healing. J Surg Res 1991 50 308 13
32. Bannon P, Wood S, Restivo T, Campbell L, Hardman MJ, Mace KA, Diabetes induces stable intrinsic changes to myeloid cells that contribute to chronic inflammation during wound healing in mice. Dis Model Mech 2013 6 1434 47
33. Stables MJ, Shah S, Camon EB, Lovering RC, Newson J, Bystrom J, Farrow S, Gilroy DW, Transcriptomic analyses of murine resolution-phase macrophages. Blood 2011 118 e192 208
34. Chiang N, Fredman G, Bäckhed F, Oh SF, Vickery T, Schmidt BA, Serhan CN, Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 2012 484 524 8
35. Badylak SF, Valentin JE, Ravindra AK, McCabe GP, Stewart-Akers AM, Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 2008 14 1835 42
36. Clària J, Nguyen BT, Madenci AL, Ozaki CK, Serhan CN, Diversity of lipid mediators in human adipose tissue depots. Am J Physiol Cell Physiol 2013 304 C1141 9
37. Bourlier V, Zakaroff-Girard A, Miranville A, De Barros S, Maumus M, Sengenes C, Galitzky J, Lafontan M, Karpe F, Frayn KN, Bouloumié A, Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation 2008 117 806 15
38. Naguib G, Al-Mashat H, Desta T, Graves DT, Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J Invest Dermatol 2004 123 87 92
39. Buck M, Houglum K, Chojkier M, Tumor necrosis factor-α inhibits collagen α1(I) gene expression and wound healing in a murine model of cachexia. Am J Pathol 1996 149 195 204
40. Kettritz R, Falk RJ, Jennette JC, Gaido ML, Neutrophil superoxide release is required for spontaneous and FMLP-mediated but not for TNFα-mediated apoptosis. J Am Soc Nephrol 1997 8 1091 100
41. Lee HN, Kundu JK, Cha YN, Surh YJ, Resolvin D1 stimulates efferocytosis through p50/p50-mediated suppression of tumor necrosis factor-α expression. J Cell Sci 2013 126 Pt 17 4037 47
42. Mirza R, DiPietro LA, Koh TJ, Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol 2009 175 2454 62
43. Scholz J, Woolf CJ, The neuropathic pain triad: Neurons, immune cells and glia. Nat Neurosci 2007 10 1361 8
44. Schäfers M, Sorkin LS, Sommer C, Intramuscular injection of tumor necrosis factor-α induces muscle hyperalgesia in rats. Pain 2003 104 579 88
45. Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S, Cytokines, nerve growth factor and inflammatory hyperalgesia: The contribution of tumour necrosis factor-α. Br J Pharmacol 1997 121 417 24
46. Schaper NC, Huijberts M, Pickwell K, Neurovascular control and neurogenic inflammation in diabetes. Diabetes Metab Res Rev 2008 24 suppl 1 S40 4
47. Novak ML, Koh TJ, Macrophage phenotypes during tissue repair. J Leukoc Biol 2013 93 875 81
48. Li L, Wu Y, Wang Y, Wu J, Song L, Xian W, Yuan S, Pei L, Shang Y, Resolvin D1 promotes the interleukin-4-induced alternative activation in BV-2 microglial cells. J Neuroinflammation 2014 11 72
49. Bang S, Yoo S, Yang TJ, Cho H, Kim YG, Hwang SW, Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. Br J Pharmacol 2010 161 707 20